Form 483

Covidien, LP Form 483, 2012-02-09

FDA issued a Form 483 to Covidien, LP on 2012-02-09 with 6 public-safe observations.

483· Form 483 issued6 observations

Covidien, LP · North Haven, United States · Issued February 9, 2012

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Feb 2012
21 CFR 806.10(a)(2)

Report of violation of the Act (see 803.52(e)(9))

Cited by Jeffrey J Thibodeau, Edward J Janik

9 Feb 2012
21 CFR 806.30

Access not permitted

Cited by Jeffrey J Thibodeau, Edward J Janik

9 Feb 2012
21 CFR 820.70(a)

Process control procedures, Lack of or inadequate procedures

Cited by Jeffrey J Thibodeau, Edward J Janik

9 Feb 2012
21 CFR 820.75(a)

Documentation

Cited by Jeffrey J Thibodeau, Edward J Janik

9 Feb 2012
21 CFR 820.100(b)

Documentation

Cited by Jeffrey J Thibodeau, Edward J Janik

Inspected site

CLCovidien, LPNorth Haven, United States

Inspection team

EJEdward J Janik

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 806.10(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 806.30Cited across public-safe Form 483 observations1x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.120Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere